Gene Therapy Shows Promise for Cutting LDL in Half in Tough-to-Treat Dyslipidemia

(MedPage Today) — NEW ORLEANS – A single injection of a gene-edited protein was deemed productive and safe in patients with dyslipidemia that was unresponsive to lipid-lowering therapy, according to a phase I trial.
IV CTX310 is an in vivo…